Health Alert:

See the latest Coronavirus Information including vaccinations, testing sites, visitation restrictions, and more.

The Gastrointestinal Malignancies Clinical Program provides compassionate, multidisciplinary care that is informed by research to develop the most effective therapies for gastrointestinal malignancies including, esophageal, stomach, colon and rectal, pancreatic, liver and bile duct cancers, and neuroendocrine tumors. Our nationally recognized specialty physicians provide education, care and support needed to help patients navigate their diagnosis and treatment plan.

Doctor with patientPenn GI Cancer Program has a comprehensive team sub-specialist medical oncologists, GI cancer surgeons, radiation oncologist, pathologists, radiologists, nurse practitioners, and oncology nurse navigators. This group meets weekly to discuss treatment plans for patients, resulting in advanced and personalized treatment plans for each patient.

Penn physicians also conduct clinical research and other investigations to improve the ability to diagnose and treat patients with all types of gastrointestinal malignancies. It is through such research that clinicians improve current modalities and develop future cancer treatments and care.

These studies include:

  • Assessment of new therapies for all stages of gastrointestinal malignancies, including studies combining surgery, radiation, immunotherapy and other local therapies and chemotherapy.
  • Assessment of new experimental agents for the treatment of patients with advanced gastrointestinal malignancies, including phase 1 clinical trials.
  • Quality-of-life studies.
  • Analysis of tissue, blood, and tumor samples to better understand the biology of the malignancies and relationship to patient outcomes.

Medical oncologists involved in the management of gastrointestinal cancer include:

Related Links:

Share This Page: